We are live on ! Find out more
BC

Bruce & Co Portfolio holdings

AUM $369M Turnover 0%
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
-3.05%
1 Year Est. Return
+50.95%
3 Year Est. Return
+94.54%
5 Year Est. Return
+93.1%
10 Year Est. Return
+271.31%
AUM
$370M
AUM Growth
-$21.1M
Cap. Flow
-$40.3M
Cap. Flow %
-10.9%
Top 10 Hldgs %
65.7%
Holding
48
New
–
Increased
–
Reduced
4
Closed
–
Avg Time Held
2.6 years
Top 10 Avg Time Held
2.3 years
Top 20 Avg Time Held
2 years

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
SUPN icon
Supernus Pharmaceuticals
SUPN
+$1.36M
2
AGEN icon
Agenus
AGEN
+$455K
3
RLI icon
RLI Corp
RLI
+$206K
4
UHAL icon
U-Haul Holding Co
UHAL
+$89.3K

Sector Composition

Rank Sector Weight
1 Utilities 30.91%
2 Healthcare 17.54%
3 Industrials 17.21%
4 Miscellaneous 14.05%
5 Financials 7.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
UHAL icon
1
U-Haul Holding Co
UHAL
$10.8B
$62.6M 16.91%
1,931,150
-2,500
-0.1% -$89.3K
2013 Q2
13 quarters
NEE icon
2
NextEra Energy
NEE
$172B
$29.4M 7.95%
972,800
– –
2013 Q2
13 quarters
DUK icon
3
Duke Energy
DUK
$97.4B
$27.5M 7.42%
347,788
– –
2014 Q3
8 quarters
ALL icon
4
Allstate
ALL
$64B
$22.7M 6.13%
333,800
– –
2013 Q2
13 quarters
CMS icon
5
CMS Energy
CMS
$21.8B
$22.1M 5.96%
538,300
– –
2014 Q3
8 quarters
XEL icon
6
Xcel Energy
XEL
$48.8B
$19.7M 5.34%
481,600
– –
2013 Q2
13 quarters
MRK icon
7
Merck
MRK
$358B
$15.8M 4.28%
271,851
– –
2013 Q2
13 quarters
PFE icon
8
Pfizer
PFE
$171B
$15M 4.06%
479,920
– –
2013 Q2
13 quarters
ABBV icon
9
AbbVie
ABBV
$505B
$14.4M 3.9%
232,915
– –
2013 Q2
13 quarters
IBM icon
10
IBM
IBM
$240B
$13.6M 3.67%
90,479
– –
2013 Q2
13 quarters
AVA icon
11
Avista
AVA
$3.16B
$10.7M 2.89%
261,000
– –
2014 Q3
8 quarters
FTK icon
12
Flotek Industries
FTK
$866M
$9.8M 2.64%
110,723
– –
2013 Q2
13 quarters
ABT icon
13
Abbott
ABT
$179B
$9.7M 2.62%
230,915
– –
2013 Q2
13 quarters
SIRI icon
14
SiriusXM
SIRI
$9.31B
$8.24M 2.23%
197,255
– –
2014 Q4
7 quarters
BG icon
15
Bunge Global
BG
$19.8B
$5.9M 1.59%
100,000
– –
2013 Q2
13 quarters
SUPN icon
16
Supernus Pharmaceuticals
SUPN
$2.37B
$3.78M 1.02%
164,581
-60,000
-27% -$1.36M
2014 Q2
9 quarters
CPN
17
DELISTED
Calpine Corporation
CPN
$3.54M 0.96%
294,849
– –
2013 Q2
13 quarters
GAN icon
18
DELISTED
GAINSCO, INC COM STK
GAN
$3.45M 0.93%
246,541
– –
2013 Q2
13 quarters
FOCL icon
19
EDAP TMS S.A.
FOCL
$197M
$3.14M 0.85%
1,045,494
– –
2013 Q2
13 quarters
RLI icon
20
RLI Corp
RLI
$5.95B
$3M 0.81%
88,240
-6,000
-6% -$206K
2013 Q2
13 quarters
ASH icon
21
Ashland
ASH
$3.34B
$2.88M 0.78%
51,100
– –
2013 Q2
13 quarters
AES.PRC.CL icon
22
DELISTED
AES Corporation Class C Preferred
AES.PRC.CL
$2.37M 0.64%
46,400
– –
2013 Q2
13 quarters
ACTA
23
DELISTED
Actua Corp
ACTA
$1.82M 0.49%
140,000
– –
2013 Q2
13 quarters
ASTC icon
24
Astrotech Corp
ASTC
$10.6M
$1.76M 0.48%
7,134
– –
2013 Q2
13 quarters
WEC icon
25
WEC Energy
WEC
$36.2B
$1.43M 0.39%
24,252
– –
2015 Q2
5 quarters

Similar funds

Bruce & Co's Q3 2016 Portfolio in Review

As of Q3 2016, Bruce & Co held 48 positions worth $370M, down 5.4% from $391M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Bruce & Co withdrew a net $40.3M in Q3 2016, reducing 4 holdings. Its largest reduction was Supernus Pharmaceuticals, cutting an estimated $1.36M.

By sector, the portfolio is most concentrated in Utilities at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Industrials.

  • Bruce & Co's biggest Q3 2016 reduction was Supernus Pharmaceuticals, cutting an estimated $1.36M.
  • Bruce & Co's ten largest holdings make up 66% of its $370M portfolio in Q3 2016.
  • Bruce & Co opened 0 new positions and closed 0 in Q3 2016.
  • Bruce & Co's portfolio value fell 5.4% quarter-over-quarter to $370M.

Based on Bruce & Co's 13F filing for Q3 2016, filed 14 Nov 2016.